Because the effects of estrogens are mediated largely through canonical ERs, primarily ERα and ERβ, the alterations in ERs levels that are observed in various regions of the brain in patients with glioma may be relevant to cancer malignancy. The gene discussed is ESR2; the disease is cancer.